The role of interleukin 15 in mounting an immune response against microbial infections

Microbes and Infection

Volumn 2, Issue 4, 2000, Pages 381-389

  Yoshikai, Yasunobu ^a   Nishimura, Hitoshi ^a  

^a Res Inst Dis Mechanism Contr   (Japan)

Author keywords

CD8 T cells; IL 15; Infection, bacteria, virus; NK cells; Protection; T cells

Indexed keywords

INTERLEUKIN 15;

ANTIBODY PRODUCTION; B LYMPHOCYTE ACTIVATION; BACTERIAL INFECTION; CYTOKINE RELEASE; CYTOTOXICITY; HOST RESISTANCE; HUMAN; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

BACTERIA (MICROORGANISMS);

EID: 0034095297     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00329-4     Document Type: Review

References (51)

1. Grabstein K.H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M.A., Ahdieh M., Johnson L., Alderson M.R., Watson J.D., Anderson D.M., Giri J.G. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science (Wash. DC). 264:1994;965-968.
2. Bamford R.N., Grant A.J., Burton J.D., Peters C., Kurys G., Goldman C.K., Brennan J., Roessler E., Waldmann T.A. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA. 91:1994;4940-4944.
3. Giri J.G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L.S., Cosman D., Anderson D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:1994;2822-2830.
4. Carson W.E., Giri J.G., Lindemann M.J., Linett M.L., Ahdieh M., Paxton R., Anderson D., Eisenmann J., Grabstein K., Caligiuri M.A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. M. 180:1994;1395-1403.
5. Armitage R.J., Macduff B.M., Eisenman J., Paxton R., Grabstein K.H. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:1995;483-490.
6. Tagaya Y., Bamford R.N., Defilippis A.P., Waldmann T.A. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity. 4:1996;329-336.
7. Nishimura H., Washizu J., Nakamura N., Enomoto A., Yoshikai Y. Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA. J. Immunol. 160:1998;936-942.
8. Onu A., Pohl T., Krause H., Bulfone-Paus S. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J. Immunol. 158:1997;255-262.
9. Bamford R.N., Battiata A.P., Burton J.D., Sharma H., Waldmann T.A. Interleukin (IL) 15/ IL-T production by the adult T-cell leukemia cell line Hut-102 is associated with a human T-cell lymphotrophic virus type I R region/IL-15 fusion message that lacks many upstream AUGs that normally attenuate IL-15 mRNA translation. Proc. Natl. Acad. Sci. USA. 93:1996;2897-2902.
10. Bamford R.N., Battiata A.P., Waldmann T.A. IL-15: The role of translational regulation in their expression. J. Leukoc. Biol. 54:1996;476-480.
11. Meazza R., Gaggero A., Neglia F., Basso S., Sforzini S., Pereno R., Azzarone B., Ferrini S. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides. Eur. J. Immunol. 27:1997;1049-1054.
12. Bamford R.N., Defilippis A.P., Azimi N., Kurys G., Waldmann T.A. The 5'untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control. J. Immunol. 160:1998;4418-4426.
13. Gaggero A., Azzarone B., Andrei C., Mishal Z., Meazza R., Zappia E., Rubartelli A., Ferrini S. Differential intracellular trafficking, secretion and endosomallocalization of two IL-15 isoforms. Eur. J. Immunol. 29:1999;1265-1274.
14. Waldmann T.A., Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17:1999;19-49.
15. + T cell-mediated immunity against Toxoplasma gondii infection in mice. J. Immunol. 157:1996;2103-2108.
16. Mody C.H., Spurrell J.C., Wood C.J. Interleukin-15 induces antimicrobial activity after release by Cryptococcus neoformans-stimulated monocytes. J. Infect. Dis. 178:1998;803-814.
17. Vazquez N., Walsh T.J., Friedman D., Chanock S.J., Lyman C.A. Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect. Immun. 66:1998;145-150.
18. Nishimura H., Hiromatsu K., Kobayashi N., Grabstein K.H., Paxton R., Sugamura K., Bluestone J.A., Yoshikai Y. IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection. J. Immunol. 156:1996;663-669.
19. Takano M., Nishimura H., Kimura Y., Mokuno Y., Washizu J., Itohara S., Nimura Y., Yoshikai Y. Protective roles of gamma delta T cells and interleukin-15 in Escherichia coli infection in mice. Infect. Immun. 66:1998;3270-3278.
20. Hirose K., Suzuki H., Nishimura H., Mitani A., Washizu J., Matsuguchi T., Yoshikai Y. Interleukin-15 might be responsible early activation of intestinal intraepithelial lymphocytes after oral infection with Listeria monocytogenes in rats. Infect. Immun. 66:1998;5677-5683.
21. Doherty T.M., Seder R.A., Sher A. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:1996;735-741.
22. Jullien D., Sieling P.A., Uyemura K., Mar N.D., Rea T.H., Modlin R.L. IL-15, an immunomodulator of T cell responses in intracellular infection. J. Immunol. 158:1997;800-806.
23. Chehimi J., Marshall J.D., Salvucci O., Frank I., Chehimi S., Kawecki S., Bacheller D., Rifat S., Chouaib S. IL-15 enhances immune functions during HIV infection. J. Immunol. 158:1997;5978-5987.
24. Flamand L., Stefanescu I., Menez J. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J. Clin. Invest. 97:1996;1373-1381.
25. Atedzoe B.N., Ahmad A., Menezes J. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J. Immunol. 159:1997;4966-4972.
26. Kakumu S., Okumura A., Ishikawa T., Yano M., Enomoto A., Nishimura H., Yoshioka K., Yoshikai Y. Serum levels of IL-10, IL-15 and soluble tumor necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clin. Exp. Immunol. 109:1997;458-463.
27. Inagaki-Ohara K., Nishimura H., Mitani A., Yoshikai Y. Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing γδ T cell receptor in mice. Eur. J. Immunol. 27:1997;2885-2891.
28. Suzuki H., Kundig T.M., Furlonger C., Wakeham A., Timms E., Matsuyama T., Schmits R., Simard J.J., Ohashi P.S., Griesser H. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science. 268:1995;1472-1476.
29. Disanto J.P., Muller W., Guy-Grand D., Fischer A., Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA. 92:1995;377-381.
30. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:1993;253-261.
31. Thomis D.C., Gurniak C.B., Tivol E., Sharpe A.H., Berg L.J. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science. 270:1995;794-797.
32. Ogasawara K., Hida S., Azimi N., Tagaya Y., Sato T., Yokochi-Fukuda T., Waldmann T.A., Taniguchi T., Taki S. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature. 391:1998;700-703.
33. +T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. M. 187:1998;967-972.
34. Lodolce J.P., Dlboone S.C.H.A.I., Reswain T., Dassopoulo S., Strettin A.M.A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 9:1998;669-676.
35. Bulfone-Paus S., Ungureanu D., Pohl T., Lindner G., Paus R., Ruckert R., Krause H., Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat. M. 10:1997;1124-1128.
36. Garcia V.E., Jullien D., Song M., Uyemura K., Shuai K., Morita C.T., Modlin R.L. IL-15 enhances the response of human gamma delta T cells to nonpeptide microbial antigens. J. Immunol. 160:1998;4322-4329.
37. Carson W.E., Ross M.E., Baiocchi R.A., Marien M.J., Boiani N., Grabstein K., Caligiuri M.A. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J. Clin. Invest. 96:1995;2578-2582.
38. Perera L.P., Goldman C.K., Waldmann T.A. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J. Immunol. 162:1999;2606-2612.
39. Estess P., Nandi A., Mohamadzadeh M., Siegelman M.H. Interleukin 15 induced endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathways in vivo. J. Exp. M. 190:1999;9-14.
40. Anderson D.M., Johnson L., Glaccum M.B., Copeland N.G., Gilbert D.J., Jenkins N.A., Valentine V., Kirstein M.N., Shapiro D.N., Morris S.W. Chromosomal assignment and genomic structure of IL-15. Genomics. 25:1995;701-706.
41. Azimi N., Brown K., Bamford R.N., Tagaya Y., Siebenlist U., Waldmann T.A. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site. Proc. Natl. Acad. Sci. USA. 95:1998;2452-2457.
42. Washizu J., Nishimura H., Nakamura N., Nimura Y., Yoshikai Y. NF-κB binding site is essential for transcriptional activation of IL-15. Immunogenetics. 48:1998;1-7.
43. Tagaya Y., Kurys G., Thies T.A., Losi J.M., Azimi N., Hanover J.A., Bamford R.N., Waldmann T.A. Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc. Natl. Acad. Sci. USA. 94:1997;11111-11119.
44. Alleva D.G., Kaser S.B., Monroy M.A., Fenton M.J., Beller D.I. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J. Immunol. 159:1997;2941-2951.
45. Girard D., Paquet M.E., Paquin R., Beaulieu A.D. Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15. Blood. 88:1996;3176-3184.
46. Hirose K., Nishimura H., Matsuguchi T.A.N.D., Yoshikai Y. Endogenous IL-15 might be responsible for early protection by natural killer cells against infection with avirulent strain of Salmonella choleraesuis in mice. J. Leukoc. Biol. 66:1999;282-390.
47. Cui J., Shin T., Kawano T., Sato H., Kondo E., Toura I., Taniguchi M. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1997;1623-1625.
48. Tagaya Y., Burton J.D., Miyamoto Y., Waldmann T.A. Identification of a novel receptor /signal transduction pathwayfor IL-15/T in mast cells. EMBO J. 1998;4928-4939.
49. Kennedy M.K., Glaccum M., Brown S.N., Butz E.A., Viney J.L., Embers M., Matsuki N., Charrier K., Sedger L., Willis C.R., Brasel K., Morrissey P.J., Stocking K., Schuh J.C.L., Joyce S., Peschon J.J. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. M. 191:2000;771-780.
50. Nishimura H., Yajima T., Naiki Y., Tsunobuchi H., Umemura M., Itano K., Matsuguchi T., Suzuki M., Ohashi P., Yoshikai Y. Differential roles of IL-15 mRNA isoforms Generated by alternative splicing in immune responses in vivo. J. Exp. M. 191:2000;157-170.
51. Zhang X., Sun S., Hwang I., Tough D.F., Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity. 5:1998;591-599.